Capecitabin Zentiva 150 mg
Capecitabin Zentiva 150 mg is a medicine authorised by Swissmedic under authorisation number 70021. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 August 2025 and the authorisation is limited until 16 August 2030. ATC code L01BC06 places the medicine in the group Antineoplastic agents.
| Authorisation number | 70021 |
|---|---|
| Name | Capecitabin Zentiva 150 mg |
| Full name | Capecitabin Zentiva 150 mg, Filmtabletten |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01BC06 |
| First authorisation | 15 August 2025 |
| Authorisation validity | 16 August 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Capecitabin Zentiva 150 mg, Filmtabletten | A | 15 August 2025 |
| 2 | Capecitabin Zentiva 500 mg, Filmtabletten | A | 15 August 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 60 | Tablette(n) | L01BC06 | 07.16.1. | A |
| 4 | 120 | Tablette(n) | L01BC06 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Capecitabin Zentiva 150 mg authorised in Switzerland?
Yes. Capecitabin Zentiva 150 mg is authorised by Swissmedic under authorisation number 70021, data as of 01 September 2026. The authorisation is limited until 16 August 2030.
Which dispensing category does Capecitabin Zentiva 150 mg have?
Capecitabin Zentiva 150 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Capecitabin Zentiva 150 mg?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.